Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.582
-0.043 (-6.86%)
At close: Dec 4, 2024, 4:00 PM
0.580
-0.002 (-0.38%)
After-hours: Dec 4, 2024, 5:21 PM EST

Bolt Biotherapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Revenue
9.787.885.731.260.230.22
Upgrade
Revenue Growth (YoY)
35.86%37.48%354.68%445.45%7.44%-
Upgrade
Cost of Revenue
62.0761.5473.1275.6640.3626
Upgrade
Gross Profit
-52.29-53.67-67.39-74.4-40.13-25.79
Upgrade
Selling, General & Admin
20.0422.5322.9318.399.065.18
Upgrade
Operating Expenses
20.0422.5322.9318.399.065.18
Upgrade
Operating Income
-72.33-76.2-90.32-92.79-49.18-30.97
Upgrade
Interest & Investment Income
6.1472.220.280.20.52
Upgrade
Other Non Operating Income (Expenses)
----6.08-11.75-0.04
Upgrade
Pretax Income
-65.09-69.2-88.1-98.59-60.73-30.49
Upgrade
Net Income
-65.09-69.2-88.1-98.59-60.73-30.49
Upgrade
Net Income to Common
-65.09-69.2-88.1-98.59-60.73-30.49
Upgrade
Shares Outstanding (Basic)
3838373322
Upgrade
Shares Outstanding (Diluted)
3838373322
Upgrade
Shares Change (YoY)
1.02%1.21%12.54%1479.05%5.46%20.76%
Upgrade
EPS (Basic)
-1.71-1.83-2.36-2.97-28.89-15.29
Upgrade
EPS (Diluted)
-1.71-1.83-2.36-2.97-28.89-15.29
Upgrade
Free Cash Flow
-61.17-69.73-78.46-59.4-50.57-26.85
Upgrade
Free Cash Flow Per Share
-1.61-1.84-2.10-1.79-24.05-13.47
Upgrade
Operating Margin
-739.68%-967.45%-1576.56%-7364.13%-21290.91%-14404.19%
Upgrade
Profit Margin
-665.56%-878.58%-1537.76%-7824.68%-26289.18%-14180.00%
Upgrade
Free Cash Flow Margin
-625.53%-885.36%-1369.47%-4714.60%-21891.77%-12488.84%
Upgrade
EBITDA
-70.51-74.34-88.66-91.6-48.57-30.63
Upgrade
D&A For EBITDA
1.821.851.671.190.610.34
Upgrade
EBIT
-72.33-76.2-90.32-92.79-49.18-30.97
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.